Zepbound in Short Supply at Amazon, Rite Aid, Pharmacies Confirm

March 28, 2024, 3:51 PM UTC

Rite Aid Corp. and Amazon Pharmacy confirmed that Eli Lilly & Co.’s new weight-loss drug Zepbound is in short supply, as patient, pharmacist and doctor complaints mount.

The US Food and Drug Administration doesn’t currently consider the obesity shot in short supply and Lilly has said the drug is “available for pharmacies across the US to order from their wholesaler.” Yet multiple pharmacists across the US told Bloomberg News earlier this week that some or all of the doses of the drug were on backorder, as demand has soared since the shot’s December launch.

On the website of ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.